Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
Open Access
- 22 January 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 98 (3), 636-640
- https://doi.org/10.1038/sj.bjc.6604175
Abstract
Among the 51 823 postmenopausal women in the Swedish Mammography Cohort, we investigated breast cancer risk in relation to the FFQ-based estimated lignan intake by oestrogen receptor (ER) and progesterone receptor (PR) subtypes. A significant 17% risk reduction for breast cancer overall in the high lignan quartile was observed, especially among PMH user (Pinteraction<0.010), but no heterogeneity across ER/PR subtypes.Keywords
This publication has 66 references indexed in Scilit:
- Dietary Lignan Intake and Postmenopausal Breast Cancer Risk by Estrogen and Progesterone Receptor StatusJNCI Journal of the National Cancer Institute, 2007
- Plasma Phytoestrogens and Subsequent Breast Cancer RiskJournal of Clinical Oncology, 2007
- Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor statusBreast Cancer Research and Treatment, 2006
- Dietary Phytoestrogen, Serum Enterolactone and Risk of Prostate Cancer: The Cancer Prostate Sweden Study (Sweden)Cancer Causes & Control, 2006
- Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast CancerClinical Cancer Research, 2005
- Comparing Social Groups: Wald Statistics for Testing Equality Among Multiple Logit ModelsInternational Journal of Comparative Sociology, 2004
- Phyto-oestrogen database of foods and average intake in FinlandBritish Journal of Nutrition, 2003
- Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesisNutrition and Cancer, 1992
- Stimulation of breast cancer cellsin vitro by the environmental estrogen enterolactone and the phytoestrogen equolBreast Cancer Research and Treatment, 1987